Back to company

SPECIFIC PHARMA A/S: Financial statements 2014

CVR: 33161395

SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 137,766,000 and a net result of DKK 18,713,000 compared with DKK 10,587,627 the year before. That is an increase of 129.2% compared with the year before. The profit margin was 13.6%. Equity amounted to DKK 37,299,000. The solvency ratio was 71%.

Revenue
137,766,000 kr.
Gross Profit
30,260,000 kr.
Profit/Loss
18,713,000 kr.
Equity
37,299,000 kr.
Total Assets
52,521,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014137.8 mio.30.3 mio.18.7 mio.37.3 mio.-
201360.1 mio.16.8 mio.10.6 mio.18.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on SPECIFIC PHARMA A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

Per Bornhøft Hansen joins the board of SPECIFIC PHARMA A/SNov 1, 2014

As of November 1, 2014, Per Bornhøft Hansen has joined the board of directors of SPECIFIC PHARMA A/S.

Henrik Kaastrup joins the board of SPECIFIC PHARMA A/SNov 1, 2014

As of November 1, 2014, Henrik Kaastrup has joined the board of directors of SPECIFIC PHARMA A/S.

Samia Sofie Kappe joins SPECIFIC PHARMA A/S as adm. dir.Nov 1, 2014

As of November 1, 2014, Samia Sofie Kappe is registered as adm. dir. of SPECIFIC PHARMA A/S.

Henrik Kaastrup steps down as adm. dir. of SPECIFIC PHARMA A/SNov 1, 2014

As of November 1, 2014, Henrik Kaastrup has stepped down as adm. dir. of SPECIFIC PHARMA A/S.

SPECIFIC PHARMA A/S appoints new auditorOct 10, 2014

As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of SPECIFIC PHARMA A/S.

Auditor steps down at SPECIFIC PHARMA A/SOct 10, 2014

As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of SPECIFIC PHARMA A/S.

NOMECO A/S registered as owner of SPECIFIC PHARMA A/SSep 15, 2014

As of September 15, 2014, NOMECO A/S is registered as an owner of SPECIFIC PHARMA A/S with an ownership share of 100%.

Henrik Kaastrup joins SPECIFIC PHARMA A/S as adm. dir.Jul 4, 2014

As of July 4, 2014, Henrik Kaastrup is registered as adm. dir. of SPECIFIC PHARMA A/S.

Ulf Blangsted Henriksen steps down as adm. dir. of SPECIFIC PHARMA A/SJun 29, 2014

As of June 29, 2014, Ulf Blangsted Henriksen has stepped down as adm. dir. of SPECIFIC PHARMA A/S.

Kristine Sakstrup Haag joins the board of SPECIFIC PHARMA A/SApr 28, 2014

As of April 28, 2014, Kristine Sakstrup Haag has joined the board of directors of SPECIFIC PHARMA A/S.

About SPECIFIC PHARMA A/S

SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The company is owned by NOMECO A/S. The company has 24 employees. In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity amounted to DKK 98,645,000.